[1]
Al-Shimran, B.A. et al. 2026. Incidence and Risk Factors of Hypersensitivity Reactions to Intravenous Ceftriaxone in Iraqi Hospitals: Nationwide Prospective Study. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 10, 2 (Apr. 2026), 50–57. DOI:https://doi.org/10.54133/ajms.v10i2.2694.